Home > Specialists > Breast Surgery > Dr. Keda Yu (余科达)
Specialty & Clinical Focus:
Breast surgery specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on radical and breast-conserving surgery, oncoplastic procedures, breast reconstruction, locally advanced breast cancer, postoperative integrated treatment, and triple-negative breast cancer.
Professional Title & Qualifications:
Chief Physician
Professor & Doctoral Supervisor
MD, PhD in Oncology
Administrative Deputy Director of the Department of Breast Surgery
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Breast Surgery
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Keda Yu (余科达) - Breast Surgery Specialist
Personal Biography
Dr. Keda Yu is Chief Physician, Professor, Doctoral Supervisor, and Administrative Deputy Director of the Department of Breast Surgery at Fudan University Shanghai Cancer Center. With more than 17 years of specialized clinical experience, his focus includes radical and breast-conserving surgery, breast reconstruction, locally advanced breast cancer, postoperative integrated treatment, and triple-negative breast cancer.
He earned a PhD in Oncology from Fudan University Shanghai Medical College and spent one year as a visiting scholar at the Methodist Hospital Cancer Center of Baylor College of Medicine in the United States. His international academic exchanges have included the UK, Germany, France, and Japan. Dr. Yu received the National Science Fund for Distinguished Young Scholars and has published more than 80 SCI-indexed papers, reflecting an active research focus alongside his clinical practice.
Why Consider Dr. Keda Yu for Your Breast Cancer Care?
Dr. Keda Yu combines more than 17 years of specialized breast surgery experience at Fudan University Shanghai Cancer Center with doctoral training in oncology and international experience at Baylor College of Medicine. His clinical scope includes radical and breast-conserving surgery, oncoplastic techniques, breast reconstruction, locally advanced breast cancer, postoperative integrated treatment, and triple-negative breast cancer.
For international patients with complex pathology, previous treatment, or questions about surgical and reconstructive options, a specialist review before travel can help clarify the next steps. Organizing pathology reports, imaging, treatment summaries, and priority questions allows Dr. Yu’s team to review the case, provide an opinion and recommendations, and address patient questions before an in-person visit to Shanghai is considered. His research background, including findings incorporated into NCCN, ASCO, and CBCS guidelines, adds context for an evidence-based discussion of potential pathways.
Pre-Travel Case Review & Specialist Liaison
Before making international travel arrangements, patients can request MedBridgeNZ coordination for a remote specialist-review pathway with Dr. Yu’s department. We organize client-authorized preparation and transfer of pathology reports, imaging, treatment summaries, and priority questions, with translation coordination where required, and manage appointment communication with Fudan University Shanghai Cancer Center.
Once the review is arranged, the relevant hospital specialist reviews the submitted records, provides an opinion and recommendations, and addresses the patient’s questions. This pre-travel step can clarify the possible care pathway and practical travel requirements before the patient decides whether to pursue an in-person visit to Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Keda Yu
Areas of Expertise
Radical Surgery for Breast Cancer: Proficiency in various radical mastectomy techniques.
Breast-Conserving Surgery: Specialized in oncoplastic techniques to preserve breast aesthetics.
Breast Reconstruction: Expert in reconstruction using latissimus dorsi flaps or prosthetic implants.
Locally Advanced Breast Cancer: Comprehensive diagnosis and multidisciplinary management.
Postoperative Integrated Treatment: Tailored adjuvant and systemic therapies for long-term recovery.
Triple-Negative Breast Cancer (TNBC): Advanced research and clinical focus on refractory subtypes.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
11,500 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Administrative Deputy Director & Chief Physician, Department of Breast Surgery, Fudan University Shanghai Cancer Center (Present)
Visiting Scholar, Methodist Hospital Cancer Center, Baylor College of Medicine, USA (1 year)
Clinical practitioner with over 17 years of specialized surgical experience at Fudan University Shanghai Cancer Center
Education & Training
PhD in Oncology, Fudan University Shanghai Medical College
Visiting Scholar, Methodist Hospital Cancer Center, Baylor College of Medicine, USA (1 year)
Awards & Honors
National Science Fund for Distinguished Young Scholars (2023)
National Science Fund for Excellent Young Scholars (2017)
Shanghai Silver Snake Award (银蛇奖) - the highest honor for young medical professionals in Shanghai
First Prize of Science and Technology Progress, awarded by the Ministry of Education, Shanghai Municipal Government, and China Anti-Cancer Association (multiple times)
American AACR International Young Investigator Award
Presidential Award of Fudan University
Top Ten Medical Youth of Shanghai
Academic & Professional Memberships
Chairman, Breast Cancer Youth Group, Oncology Branch of the Chinese Medical Association
Executive Member & Secretary-General, Breast Cancer Professional Committee, China Anti-Cancer Association (CACA)
Chairman, Breast Cancer Professional Committee, Shanghai Anti-Cancer Association
Vice Chairman, Tumor Molecular Target Branch, Shanghai Medical Association
Council Member, Youth Council of China Anti-Cancer Association (CACA)
Research & Publications
Published over 80 SCI-indexed papers in medical journals including JAMA Oncology, Journal of Clinical Oncology (JCO), Lancet Oncology, Nature Reviews Cancer, and Nature Communications
Research cited over 4,000 times in international medical literature
Principal investigator for more than 10 national and provincial-level research projects, including projects funded by the National Natural Science Foundation of China
Editor-in-Chief of 2 specialized academic monographs on breast cancer
Research findings integrated into international and domestic clinical guidelines, including NCCN, ASCO, and CBCS
Selected Peer-Reviewed Publications
Selected peer-reviewed publications:
Yu KD et al. Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020;6(9):1390–1396. PMID: 32789480
Yu KD et al. Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial. Lancet Reg Health West Pac. 2021;11:100158. PMID: 34327363
Jiang YZ, Yu KD, et al. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell. 2019;35(3):428–440.e5. PMID: 30853353
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Keda Yu review my type of breast cancer before I travel to China?
Dr. Yu’s clinical focus includes locally advanced breast cancer, triple-negative breast cancer, radical and breast-conserving surgery, oncoplastic procedures, and breast reconstruction using flaps or implants. MedBridgeNZ can coordinate a pre-travel specialist-review request by preparing and transferring your pathology reports, imaging, treatment summary, and priority questions to his department with your authorization. Once the review pathway is confirmed, the relevant hospital specialist reviews the submitted records, provides an opinion and recommendations, and answers your questions. This can help you decide whether an in-person assessment in Shanghai is worth considering before making travel arrangements.
How can an international patient request an appointment or remote review with Dr. Yu?
Contact MedBridgeNZ with your available medical records and preferred review pathway. We coordinate record preparation, translation where required, client-authorized document transfer, and appointment-request communication with Fudan University Shanghai Cancer Center. Scheduling follows the hospital’s process and Dr. Yu’s availability. Once a remote review is arranged, the specialist team reviews the submitted materials and provides its opinion, recommendations, and responses to your questions. MedBridgeNZ then helps coordinate the next administrative steps based on the hospital’s reply.
What support is available if I decide to travel to Shanghai after the review?
After the remote review, MedBridgeNZ can coordinate the non-clinical steps for an in-person hospital pathway, including appointment communication, medical invitation or visa-document coordination support, travel and accommodation planning, translation coordination, and bilingual administrative support during hospital visits where arranged. Dr. Yu and the relevant Fudan University Shanghai Cancer Center team remain responsible for medical opinions, diagnostic decisions, treatment recommendations, and clinical care. The review helps patients prepare their records, questions, and practical arrangements before travelling to Shanghai.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment-request communication, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel and accommodation planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment. Clinical opinions and recommendations are provided by the relevant hospital or licensed specialist, and third-party medical and travel costs remain separate unless expressly stated in writing.